Vitamin K1 - Phytonadione Injection, Emulsion
NDC Package 51662-1536-3

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Frequently Asked Questions

Package Information

Vitamin K1 - Phytonadione injection is vitamin K1 Injection (Phytonadione Injectable Emulsion, USP) is indicated in the following coagulation disorders which are due to faulty formation of factors II, VII, IX and X when caused by vitamin K deficiency or interference with vitamin K activity.Vitamin K1 Injection is indicated in:anticoagulant-induced prothrombin deficiency caused by coumarin or indanedione derivatives;prophylaxis and therapy of hemorrhagic disease of the newborn;hypoprothrombinemia due to antibacterial therapy;hypoprothrombinemia secondary to factors limiting absorption or synthesis of vitamin K, e.g., obstructive jaundice, biliary fistula, sprue, ulcerative colitis, celiac disease, intestinal resection, cystic fibrosis of the pancreas, and regional enteritis;other drug-induced hypoprothrombinemia where it is definitely shown that the result is due to interference with vitamin K metabolism, e.g., salicylates. This formulation utilizes a injection, emulsion delivery system. Marketed by Hf Acquisition Co Llc, Dba Healthfirst, this product is identified by NDC 51662-1536 and is authorized under FDA application ANDA087955.

Identification & Billing

NDC Package Code
51662-1536-3
Package Description
25 POUCH in 1 BOX / 1 AMPULE in 1 POUCH (51662-1536-2) / 1 mL in 1 AMPULE
Product Code
51662-1536
11-Digit Billing Format
51662153603
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Vitamin K1 - Phytonadione
Non-Proprietary Name
Vitamin K1 - Phytonadione
Substance Name
Phytonadione
Dosage Form
Injection, Emulsion - An emulsion consisting of a sterile, pyrogen-free preparation intended to be administered parenterally.
Administration Route
  • Intramuscular - Administration within a muscle.
  • Intravenous - Administration within or into a vein or veins.
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
Active Ingredient(s)
PHYTONADIONE 10 mg/mL
Pharmacologic Class
Usage Information
Vitamin K1 Injection (Phytonadione Injectable Emulsion, USP) is indicated in the following coagulation disorders which are due to faulty formation of factors II, VII, IX and X when caused by vitamin K deficiency or interference with vitamin K activity.Vitamin K1 Injection is indicated in:anticoagulant-induced prothrombin deficiency caused by coumarin or indanedione derivatives;prophylaxis and therapy of hemorrhagic disease of the newborn;hypoprothrombinemia due to antibacterial therapy;hypoprothrombinemia secondary to factors limiting absorption or synthesis of vitamin K, e.g., obstructive jaundice, biliary fistula, sprue, ulcerative colitis, celiac disease, intestinal resection, cystic fibrosis of the pancreas, and regional enteritis;other drug-induced hypoprothrombinemia where it is definitely shown that the result is due to interference with vitamin K metabolism, e.g., salicylates.

Regulatory & Marketing

Labeler Name
Hf Acquisition Co Llc, Dba Healthfirst
Product Type
Human Prescription Drug
FDA Application #
ANDA087955
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
05-10-2021
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Billing & HCPCS Mapping

To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.

J3430
Source: ASP
Vitamin k phytonadione inj
HCPCS Dosage 1 MG
Units / Pkg 250

Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51662-1536-3 identifies a specific commercial package of 25 pouch in 1 box / 1 ampule in 1 pouch (51662-1536-2) / 1 ml in 1 ampule of Vitamin K1 - Phytonadione, a human prescription drug labeled by Hf Acquisition Co Llc, Dba Healthfirst. This injection, emulsion is formulated for intramuscular; intravenous; subcutaneous use and contains phytonadione as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Hf Acquisition Co Llc, Dba Healthfirst on May 10, 2021. The current certification is valid through December 31, 2026.

How is this Hf Acquisition Co Llc, Dba Healthfirst product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51662153603. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
51662-1536-3
11-Digit CMS (5-4-2)
51662-1536-03

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.